Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: Neuroprotection of dopaminergic neurons

Journal of Neurosurgery

Volumn 100, Issue 4, 2004, Pages 679-687

  Maesawa, Satoshi ^a   Kaneoke, Yoshiki ^b   Kajita, Yasukazu ^b   Usui, Naotaka ^b   Misawa, Nobuaki ^b   Nakayama, Atsuo ^b   Yoshida, Jun ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

6 hydroxydopamine; Deep brain stimulation; Neuroprotection; Parkinson disease; Rat; Subthalamic nucleus

Indexed keywords

OXIDOPAMINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; DOPAMINERGIC NERVE CELL; IMPLANTATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STEREOTAXIC SURGERY; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 1642346342     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2004.100.4.0679     Document Type: Article

References (34)

1. Benabid AL, Benazzous A, Pollak P: Mechanisms of deep brain stimulation. Mov Disord 17 (Suppl 3):S73-S74, 2002
2. Benazzouz A, Gao DM, Ni ZG, et al: Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat. Neuroscience 99:289-295, 2000
3. Benazzouz A, Hallett M: Mechanism of action of deep brain stimulation. Neurology 55 (Suppl 6):S13-S16, 2000
4. Bowenkamp KE, Lapchak PA, Hoffer BJ, et al: Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned rats. Exp Neurol 145:104-117, 1997
5. Bruet N, Windels F, Bertrand A, et al: High frequency stimulation of the subthalamic nucleus increases the extracellular contents of striatal dopamine in normal and partially dopaminergic denervated rats. J Neuropathol Exp Neurol 60:15-24, 2001
6. Cadet JL, Zhu SM: The intrastriatal 6-hydroxydopamine model of hemiparkinsonism: quantitative receptor autoradiographic evidence of correlation between circling behavior and presynaptic as well as postsynaptic nigrostriatal markers in the rat. Brain Res 595:316-326, 1992
7. Carvalho GA, Nikkhah G: Subthalamic nucleus lesions are neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions. Exp Neurol 171:405-417, 2001
8. The Deep-Brain Stimulation for Parkinson's Disease Study Group: Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 345:956-963, 2001
9. Dostrovsky JO, Lozano AM: Mechanisms of deep brain stimulation. Mov Disord 17 (Suppl 3):S63-S68, 2002
10. During MJ, Kaplitt MG, Stern MB, et al: Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. Hum Gene Ther 12:1589-1591, 2001
11. Hashimoto T, Elder CM, Okun MS, et al: Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J Neurosci 23:1916-1923, 2003
12. Henderson JM, Annett LE, Ryan LJ, et al: Subthalamic nucleus lesions induce deficits as well as benefits in the hemiparkinsonian rat. Eur J Neurosci 11:2749-2757, 1999
13. Hilker R, Voges J, Ghaemi M, et al: Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in parkinsonian humans. Mov Disord 18:41-48, 2003
14. Katayama Y, Kasai M, Oshima H, et al: Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients. J Neurosurg 95:213-221, 2001
15. Limousin P, Pollak P, Hoffmann D, et al: Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients. Mov Disord 11:231-235, 1996
16. Matsumura H, Kinoshita G, Satoh S, et al: A novel apparatus that permits multiple routes for infusions and body-fluid collections in a freely-moving animal. J Neurosci Methods 57:145-149, 1995
17. Meissner W, Harnack D, Paul G, et al: Deep brain stimulation of subthalamic neurons increases striatal dopamine metabolism and induces contralateral circling in freely moving 6-hydroxydopamine-lesioned rats. Neurosci Lett 328:105-108, 2002
18. Meissner W, Reum T, Paul G, et al: Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats. Neurosci Lett 303:165-168, 2001
19. Natsume A, Mata M, Goss J, et al: Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration. Exp Neurol 169:231-238, 2001
20. Ni ZG, Bouali-Benazzouz R, Gao DM, et al: Time-course of changes in firing rates and firing patterns of subthalamic nucleus neuronal activity after 6-OHDA-induced dopamine depletion in rats. Brain Res 899:142-147, 2001
21. Novelli A, Reilly JA, Lysko PG, et al: Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 451:205-212, 1988
22. Parent A, Hazrati LN: Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 20:128-154, 1995
23. Paul G, Reum T, Meissner W, et al: High frequency stimulation of the subthalamic nucleus influences striatal dopaminergic metabolism in the naive rat. Neuroreport 11:441-444, 2000
24. Paxinos W, Watson C: The Rat Brain in Stereotactic Coordinates, ed 4. San Diego: Academic Press, 1997
25. Perese DA, Ulman J, Viola J, et al: A 6-hydroxydopamine-induced selective parkinsonian rat model. Brain Res 494:285-293, 1989
26. Piallat B, Benazzouz A, Benabid AL: Neuroprotective effect of chronic inactivation of the subthalamic nucleus in a rat model of Parkinson's disease. J Neural Transm Suppl 55:71-77, 1999
27. Piallat B, Benazzouz A, Benabid AL: Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioral and immunohistochemical studies. Eur J Neurosci 8:1408-1414, 1996
28. Rodriguez MC, Obeso JA, Olanow CW: Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann Neurol 44 (Suppl 1):S175-S188, 1998
29. Rosenblad C, Kirik D, Bjorklund A: Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model. Exp Neurol 161:503-516, 2000
30. Salin P, Manrique C, Forni C, et al: High-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the basal ganglia in the rat. J Neurosci 22:5137-5148, 2002
31. Schwarz EJ, Alexander GM, Prockop DJ, et al: Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease. Hum Gene Ther 10:2539-2549, 1999
32. Vingerhoets FJ, Villemure JG, Temperli P, et al: Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology 58:396-401, 2002
33. Vitek JL: Mechanisms of deep brain stimulation: excitation or inhibition. Mov Disord 17 (Suppl 3):S69-S72, 2002
34. Windels F, Bruet N, Poupard A, et al: Effects of high frequency stimulation of subthalamic nucleus on extracellular glutamate and GABA in substantia nigra and globus pallidus in the normal rat. Eur J Neurosci 12:4141-4146, 2000